• Japanese
  • Korean
  • Chinese
Cover Image

Catheter Markets

Abstract

Catheters are used in a number of processes, such as: cardiovascular, urological, intravenous, oximetry, thermodilution, suction and wound drainage processes, that involve the administration or drainage of fluids from the body. The global market for catheters is vibrant and continually evolving with significant investments to improve the capabilities of existing catheters, improve safety features and identify new medical applications. The growing number of aged people undergoing diagnostic and therapeutic procedures is driving increases in catheter sales. Government regulations also play a key role, mainly in the urological catheter segment, as regulations attempt to promote fewer infections among hospitalized patients through more frequent use of catheterization. This TriMark Publications report provides a detailed analysis of the global market for catheters, including central venous catheters (CVC), peripheral venous catheters (PVC), midline catheters (MC), hemodialysis catheters, pulmonary artery catheters, peripheral artery catheters and umbilical catheters. The study also analyzes almost all of the companies known to be marketing, manufacturing or developing catheter products in the U.S. and worldwide. Detailed tables, charts and figures are included with projected sales data by geographic region for the Americas, EMRA (Europe, the Middle East, Russia, Africa) and Asia-Pacific regions.

Methodology

The author of this report is a retired college professor with more than 30 years of experience in teaching biochemistry - biochemical pharmacology, biotechnology and molecular biology. He also has four years of experience in editing market research reports on healthcare topics. Company-specific information for this report has been obtained mainly from industry trade publications, academic journals, news and research articles, press releases and corporate websites, as well as annual reports for publicly-held firms. Additionally, sources of information include the non-governmental organizations (NGOs) such as the World Health Organization (WHO) and governmental entities like the U.S. Department of Health and Human Services (FIRS) and U.S. federal agencies such as the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Where possible and practicable, the most recent data available have been used.

Some of the statistical information was taken from Biotechnology Associates' databases and from TriMark's private data stores. The information in this study was obtained from sources that we believe to be reliable, but we do not guarantee the accuracy, adequacy or completeness of any information or omission or for the results obtained by the use of such information. Key information from the business literature was used as a basis to conduct dialogue with and obtain expert opinion from market professionals regarding commercial potential and market sizes. Senior managers from major company players were interviewed for part of the information in this report.

Primary Sources

TriMark collects information from hundreds of Database Tables and many comprehensive multi-client research projects, as well as Sector Snapshots that we publish annually. We extract relevant data and analytics from TriMark' s research as part of this data collection.

Secondary Sources

TriMark uses research publications, journals, magazines, newspapers, newsletters, industry reports, investment research reports, trade and industry association reports, government-affiliated trade releases and other published information as part of its secondary research materials. The information is then analyzed and translated by the Industry Research Group into a TriMark study. The Editorial Group reviews the complete package with product and market forecasts, critical industry trends, threats and opportunities, competitive strategies and market share determinations.

Table of Contents

1. Introduction

  • 1.1. Scope of this Report
  • 1.2. Methodology
  • 1.3. Executive Summary

2. Catheter Uses and Types

  • 2.1. Scope of this Chapter
  • 2.2. Catheter Uses
  • 2.3. Types of Catheters
    • 2.3.1. Cardiovascular Catheters
  • 2.3.1.1. Cardiac Catheterization Procedures
  • 2.3.1.2. Indications for Cardiac Catheterization
    • 2.3.2. Percutaneous Coranary Intervention (PCI)
    • 2.3.3. Athrectomy
    • 2.3.4. Ventricular Angiogram
    • 2.3.5. Coronary Flow Reserve Measurements
    • 2.3.6. Intravascular Ultrasound Imaging
    • 2.3.7. Pericardiocentesis
    • 2.3.8. Heart Biopsy Catheters
    • 2.3.9. Atrial Fibrillation Catheters
    • 2.3.10. Ablation Electrophysiology Catheters
      • 2.3.10.1. New Cardiac Ablation Technology Trends
      • 2.3.10.2. Next Generation Atrial Fibrillation Ablation Catheters
  • 2.4. Urological Applications of Catheters
    • 2.4.1. Condom Catheters
    • 2.4.2. Indwelling Urethral Catheters
    • 2.4.3. Intermittent Catheters
    • 2.4.4. Dialysis Catheters
      • 2.4.4.1. Advances in Urinary Catheter Technology
      • 2.4.4.2. Biocompatibility
      • 2.4.4.3. Biofilms and Encrustation
      • 2.4.4.4. Issues in Intermittent Self-Catheterization
      • 2.4.4.5. Coatings for Urinary Catheters
  • 2.5. Neurovascular Applications of Catheters
  • 2.6. Venous Access Applications of Catheters
    • 2.6.1. Central Venous Catheters (CVC)
    • 2.6.2. Short Peripheral Inserted Catheters (PIC)
    • 2.6.3. Midline Catheters (MC)
    • 2.6.4. Peripherally Inserted Central Catheter (PICC)
    • 2.6.5. Pulmonary Artery Catheters (PAC)
    • 2.6.6. Tunneled Central Catheters
    • 2.6.7. Implanted Ports for Central Catheters
  • 2.7. Oximetric Catheter
  • 2.8. Thermodilution Catheters
  • 2.9. Suction Catheters
  • 2.10. Wound Drainage Catheters
  • 2.11. Umbilical Catheters
  • 2.12. Catheter Coating
  • 2.13. Comparison of Three Common Catheter Materials
    • 2.13.1. Silicones
    • 2.13.2. Polyvinyl Chloride
    • 2.13.3. Latex Rubber
  • 2.14. Comparison of Silicone, PVC and Latex
  • 2.15. The Making of Catheters
    • 2.15.1. History
    • 2.15.2. Raw Materials and Design

3. Disease Conditions that Fuel the Growth of Catheter Market

  • 3.1. Scope of this Chapter
  • 3.1. Cardiovascular Diseases
    • 3.1.1. Mortality from Heart Disease and Stroke in Selected OECD Countries
    • 3.1.2. Market for Cardiovascular Devices
    • 3.1.3. Market Leaders in Cardiovascular Devices
  • 3.2. Catheters and Ports in Cancer Treatment
    • 3.2.1. Cancer in the U.S.
    • 3.2.2. Mortality from Cancer in OECD Countries
    • 3.2.3. Global Oncology Market
    • 3.3. Renal Failure
    • 3.3.2. Renal Failure in OECD Countries
    • 3.3.3. Global Dialysis Market
    • 3.3.4. Number of Dialysis Patients Globally
    • 3.3.5. Number of U.S. Dialysis Patients
    • 3.3.6. U.S. Dialysis Market
    • 3.3.7. U.S. Dialysis Procedures by Segment

4. Trends in Overall Medical Device Industry

  • 4.1. Scope of this Chapter
    • 4.1.1. Global Medical Device Market
    • 4.1.2. Market for Medical Devices in Americas
    • 4.1.3. Medical Device Market in Western Europe
    • 4.1.4. Medical Device Market in Central and Eastern Europe
    • 4.1.5. Medical Device Market in Asia/Pacific
    • 4.1.6. Medical Device Market in Middle East/Africa
    • 4.1.7. Medical Device Market in China and India

5. Catheter Market: Overview

  • 5.1. Scope of this Chapter
  • 5.2. Segmentation of Catheter market
    • 5.2.1. Global Market for Catheters
    • 5.2.2. Market for Catheters in Americas
    • 5.2.3. Catheter Market in Europe, Middle East, Russia and Africa, 2011-2018
    • 5.2.4. Asia/Pacific Market for Catheters
    • 5.2.5. Catheter Market in Japan
    • 5.2.6. Global Catheter Market by Region
    • 5.2.7. Global Catheter Market by Disease Segment
  • 5.3. Market for Cardiovascular Catheters
    • 5.3.1. Global Market for Diagnostic Catheters by Type
    • 5.3.2. Global Market for Balloon Catheters
    • 5.3.3. The Rise of Balloon Catheters in the U.S.
    • 5.3.4. Fast Changing DEBs Market
    • 5.3.5. Global Market for Electrophysiology Ablation Catheters
    • 5.3.6. North American Market for Electrophysiology Ablation Catheters
    • 5.3.7. European Market for Electrophysiology Ablation Catheters
    • 5.3.8. Asia/Pacific Market for Electrophysiology Ablation Catheters
    • 5.3.9. Single-Use Cardiac Catheter market
      • 5.3.9.1. Global Market for Single-Use Catheters in Conventional Diagnostics
      • 5.3.9.2. Global Market for Single-Use Catheters Used in Standard Ablation
      • 5.3.9.3. Global Market for Single-Use Catheters Used in Advanced Diagnostics
      • 5.3.9.4. Global Market for SUD Catheters Used in Irrigated Ablation
  • 5.4. Global Market for Urological Catheters
    • 5.4.1. FDA-Approved Urological Catheters
    • 5.4.2. U.S. Urology Devices Market
    • 5.4.3. U.S. Intermittent Catheters Market
    • 5.4.4. Market Leaders in Intermittent Catheters
    • 5.4.5. Market Leaders in Foley Catheters
    • 5.4.6. U.S. Market for Urinary Incontinence Products by Type
    • 5.4.7. U.S. Urinary Incontinence Market by Segment
    • 5.4.8. Market Leaders in Male External Catheters
  • 5.5. Global Market for Central Venous Catheters
    • 5.5.1. Global Central Venous Catheter (CVC) Market by Region
    • 5.5.2. Market Leaders in Central Venous Catheter Market
    • 5.5.3. Market Leaders in Implantable Catheter Ports

6. Global Market for Tissue Ablation Devices

  • 6.1. Scope of this Chapter
    • 6.1.1. Share of the Ablation Technologies by Clinical Specialty
    • 6.1.2. Global Ablation Devices Market by Type
    • 6.1.3. Electrical and Electrocautery Devices
    • 6.1.4. Radiation Devices
    • 6.1.5. Light-Based Ablation Devices
    • 6.1.6. Radiofrequency (RF) Energy
    • 6.1.7. Market Leaders in RF Ablation Devices
    • 6.1.8. Ultrasound Energy
    • 6.1.9. Cryotherapy
    • 6.1.10. Thermal Ablation
    • 6.1.11. Microwave Hyperthermia
    • 6.1.12. Hydromechanical Ablation
  • 6.2. U.S. Market for Tissue Ablation Devices
    • 6.2.1. Cryoablation in the U.S.
    • 6.2.2. Hydromechanical Ablation Therapy in the U.S.
    • 6.2.3. `Ultrasound Tissue Ablation in the U.S.
    • 6.2.4. Radiofrequency Ablation Therapy in the U.S.
    • 6.2.5. Market for Tissue Ablation Devices in Asia/Pacific
      • 6.2.5.1. Market for Tissue Ablation Devices in Japan
      • 6.2.5.2. Chinese Market for Tissue Ablation Devices
      • 6.2.5.3. Australian Market for Tissue Ablation Devices
      • 6.2.5.4. Market for Tissue Ablation in India
  • 6.3. Share of the Ablation Technologies by Clinical Specialty
    • 6.3.1. Cancer Ablation Market by Type of Cancer
    • 6.3.2. Global Ablation Technologies Market by Modality

7. Free Standing Diagnostic Cath Lab Market in the U.S.

  • 7.1. Reimbursement Trends
  • 7.2. Joint Venture Options
  • 7.3. Payer Mix and Volume
  • 7.4. Overhead Expenses
  • 7.5. Space Requirements and Costs
  • 7.6. Personnel Staffing
  • 7.7. Credentialing Requirements and Responsible Oversight
  • 7.8. Considering Structural Alternatives

8. Coding and Payment Information for Catheters, 2012

  • 8.1. Medicare Coverage Policy
  • 8.2. Private Insurance Coverage
  • 8.3. Documentation
  • 8.4. Codes and Payments for Hospitals for Procedures Performed in Outpatient Setting
    • 8.4.1. Codes and Payments for Inpatient Procedures
    • 8.4.2. Codes and Payments for ASC Outpatient Procedures
  • 8.5. Physician Payments
    • 8.5.1. Physician Payment for Procedures Performed at a Facility
    • 8.5.2. Physician Payment Performed in a Non-Facility Setting
  • 8.6. Supplies
  • 8.7. Appeals

9. Selected Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Agiltrac 018 Peripheral Dilatation Catheter
    • 9.1.2. Fox Plus PTA Catheter
    • 9.1.3. Fox sv PTA Catheter
    • 9.1.4. FoxCross 035 PTA Catheter
    • 9.1.5. Veripath Peripheral Guiding Catheter
    • 9.1.6. Powersail Coronary Dilatation Catheter
    • 9.1.7. Rx Viatrac 14 Plus Peripheral Dilatation Catheter
    • 9.1.8. Trek & Mini Trek Coronary Dilatation Catheter
  • 9.2. Abiomed, Inc.
    • 9.2.1. Impella 2.5
    • 9.2.2. Impella 5.0
    • 9.2.3. Impella LD
  • 9.3. AngioDynamics, Inc.
    • 9.3.1. Selected Products from AngioDynamics
      • 9.3.1.1. UniFuse Infusion Catheter
      • 9.3.1.2. NeoStar™ Triple Lumen Catheter
      • 9.3.1.3. Soft-Vu 4 French High Flow
      • 9.3.1.4. Omni Flush Angiographic Catheter
      • 9.3.1.5. SOS Omni Selective Catheter
      • 9.3.1.6. Mariner™ Hydrophilic Coated Angiographic Catheter
      • 9.3.1.7. Total Abscession Drainage Catheter
      • 9.3.1.8. Accu-Vu Sizing Catheter
      • 9.3.1.9. AngiOptic Flush and Selective Catheters
      • 9.3.1.10. Profiler Balloon Dilation Catheter
      • 9.3.1.11. WorkHorse II PTA Balloon Catheter
      • 9.3.1.12. DuraMax Chronic HemoDialysis Catheter
      • 9.3.1.13. Dura-Flow Chronic Hemodialysis Catheter
      • 9.3.1.14. SCHON XL Acute Hemodialysis Catheter
      • 9.3.1.15. LifeJet VP VascPak
      • 9.3.1.16. EVENMORE Chronic Dialysis Catheter
      • 9.3.1.17. Schon Chronic Hemodialysis Catheter
      • 9.3.1.18. EMBOSAFE Valved, Splittable Sheath Dialtor
  • 9.4. Astra Tech AB
    • 9.4.1. LoFric Primo
    • 9.4.2. LoFric
    • 9.4.3. LoFric Hydro-Kit
    • 9.4.4. LoFric Dila Cath
  • 9.5. AtriCure, Inc.
  • 9.6. B. Braun Melsungen AG
    • 9.6.1. B. Braun's Intermittent Catheters
      • 9.6.1.1. Actreen® Lite Mini (Female Self Intermittent Catheter)
      • 9.6.1.2. Actreen® Lite Cath Tiemann Male
      • 9.6.1.3. Actreen® Lite Cath Nelaton Male
      • 9.6.1.4. Actreen® Lite Cath Nelaton Female
      • 9.6.1.5. Actreen® SafeCath Tiemann Male
      • 9.6.1.6. Actreen® SafeCath Nelaton Female
      • 9.6.1.7. Actreen® Glys Cath Tiemann Male
      • 9.6.1.8. Actreen® Glys Cath Nelaton Male
      • 9.6.1.9. Actreen® Glys Cath Nelaton Female
    • 9.6.2. Vesical Instillation Catheters
      • 9.6.2.1. Actreen® Glys Luer Lock Tiemann Male
      • 9.6.2.2. Actreen® Glys Luer Lock Nelaton Male
      • 9.6.2.3. Actreen® Glys Luer Lock Nelaton Female
    • 9.6.3. Male External Catheters
      • 9.6.3.1. Urimed® Vision Standard
      • 9.6.3.2. Urimed® Vision Short
    • 9.6.4. Urological Catheters
      • 9.6.4.1. Transurethral Balloon Catheter, Nelaton Tip
      • 9.6.4.2. Transurethral Balloon Catheter, Tiemann Tip
      • 9.6.4.3. Nelaton Catheter
      • 9.6.4.4. Tiemann Catheter
      • 9.6.4.5. Tiemann-Katheter with lubricant
    • 9.6.5. Female Catheter
      • 9.6.5.1. Cystofix® Basic Set (acute and medium term care)
      • 9.6.5.2. Cystofix® Replacement Set
      • 9.6.5.3. Cystofix® Dilation Replacement Set with Balloon Catheter
      • 9.6.5.4. Cystofix® Basic Set with Balloon Catheter (long term care)
      • 9.6.5.5. Cystofix® TUR
      • 9.6.5.6. Cystofix® Paed Basic Set
      • 9.6.5.7. Cystofix® Paediatrics and Neonatalogy Replacement Set
      • 9.6.5.8. Nephrofix®
      • 9.6.5.9. Nephrofix® Certo
  • 9.7. Becton, Dickinson & Co.
  • 9.8. Boston Scientific
    • 9.8.1. Boston's Advanced Mapping Catheters
      • 9.8.1.1. AFocus™ Steerable Diagnostic Catheters
      • 9.8.1.2. Constellation® Full Contact Mapping Catheter
      • 9.8.1.3. Inquiry® H-Curve™ Steerable Diagnostic Catheters
      • 9.8.1.4. Luma-Cath™ Fixed & Steerable Curve Diagnostic Catheters
      • 9.8.1.5. Ten-Ten™ Duodecapolar Diagnostic Catheters
    • 9.8.2. Boston's Diagnostic Catheters
      • 9.8.2.1. Blazer® Dx-20 Bidirectional Duodecapolar Diagnostic Catheter
      • 9.8.2.2. Explorer 360™ and 360 Jr™ Diagnostic Catheters
      • 9.8.2.3. Inquiry® Fixed Curve Diagnostic Catheters
      • 9.8.2.4. Inquiry® HIS Diagnostic Catheters
      • 9.8.2.5. Inquiry® Steerable Diagnostic Catheters
      • 9.8.2.6. Polaris Dx™ Steerable Diagnostic Catheter
      • 9.8.2.7. Polaris X™ Steerable Diagnostic Catheters
      • 9.8.2.8. SteeroCath-Dx™ Bi-Directional Steerable Diagnostic Catheters
    • 9.8.3. Boston's Therapeutic Catheters
      • 9.8.3.1. Blazer Prime® HTD and Blazer Prime® XP Temperature Catheters
      • 9.8.3.2. Blazer® II XP Temperature Ablation Catheter
      • 9.8.3.3. Blazer® Temperature Ablation Catheters
      • 9.8.3.4. Chilli IIR Cooled Ablation Catheters
    • 9.8.4. Boston's Catheters in Gasteroenterology
      • 9.8.4.1. Gold Probe™ Electrohemostasis Catheter
      • 9.8.4.2. Injection Gold Probe™ Hemostasis Catheter
    • 9.8.5. Angiographic Catheter in Interventional Radiology
      • 9.8.5.1. iCross™ Coronary Imaging Catheter
    • 9.8.6. Selected Balloon Catheter in Interventional Radiology
      • 9.8.6.1. Berenstein Large Lumen Occlusion Balloon Catheter
      • 9.8.6.2. Charger™ 0.035" Balloon Dilatation Catheter
      • 9.8.6.3. Coyote™ Balloon Dilatation Catheter
      • 9.8.6.4. Sterling® ES Balloon Dilatation Catheters
      • 9.8.6.5. Sterling® SL Balloon Dilatation Catheter
      • 9.8.6.6. Sterling™ Monorail® Balloon Dilatation Catheters
    • 9.8.7. Urology Balloon Catheters
      • 9.8.7.1. NephroMax™ High Pressure Nephrostomy Balloon Catheter
      • 9.8.7.2. UroMax Ultra™ High Pressure Balloon Catheter
  • 9.9. Coloplast A/S
    • 9.9.1. SpeediCath Control
    • 9.9.2. SpeediCath Compact
    • 9.9.3. SpeediBag Compact
    • 9.9.4. SpeediCath Complete
    • 9.9.5. SpeediCath Compact Male
    • 9.9.6. Conveen Optima
    • 9.9.7. Conveen Optima and Conveen Active
  • 9.10. Cook Medical, Inc.
    • 9.10.1. Anesthetic Injection Catheter
    • 9.10.2. Angled Tip Ureteral Catheter
    • 9.10.3. Bush DL™ Ureteral Illuminating Catheter Set
    • 9.10.4. Bush SL™ Ureteral Illuminating Catheter Set
    • 9.10.5. Cohen Deflecting Wire Guide Catheter
    • 9.10.6. Cone Tip Ureteral Catheter
    • 9.10.7. Echotip® Open-End Ureteral Catheter
    • 9.10.8. Flexi-Tip® Ureteral Catheter
    • 9.10.9. Kumpe Access Catheter
    • 9.10.10. Laser Ureteral Catheter
    • 9.10.11. Madduri Ureteral Stone Pushing Catheter
    • 9.10.12. Malleable Tip Open-End Ureteral Catheter
    • 9.10.13. Open-End Flexi-Tip® Ureteral Catheter
    • 9.10.14. Open-End Tapered Tip Ureteral Catheter
    • 9.10.15. Open-End Ureteral Catheter Sof-flex®
    • 9.10.16. Pediatric Ureteral catheter
    • 9.10.17. Pigtail Ureteral Catheter Sof-Flex® AQR
    • 9.10.18. Pigtail Ureteral Catheter Set
    • 9.10.19. Renal Access Cobra Catheter
    • 9.10.20. Round Tip Ureteral Catheter
    • 9.10.21. Rutner Universal Wedge Catheter
    • 9.10.22. Schoborg Angled Tip Laser Catheter
    • 9.10.23. Spiral Tip Ureteral Access Catheter
  • 9.11. Edwards Lifesciences Corporation
    • 9.11.1. Edward's Central Venous Catheters
      • 9.11.1.1. Vantex Antimicrobial Central Venous Catheters
      • 9.11.1.2. IntroFlex Introducers
      • 9.11.1.3. Multimed Catheters
      • 9.11.1.4. AVA 3Xi Device
      • 9.11.1.5. AVA High-Flow Device
      • 9.11.1.6. PreSep Central Venous Oximetry Catheter (ScvO2)
      • 9.11.1.7. PediaSat Oximetry Catheter (ScvO2)
    • 9.11.2. Balloon Atrioseptostomy Catheters
  • 9.12. Hollister, Inc.
    • 9.12.1. Hollister's Continence Care Products
      • 9.12.1.2. Apogee Intermittent Catheters
      • 9.12.1.3. Apogee Closed System
      • 9.12.1.4. Advance Plus Touch Free Intermittent Catheter
      • 9.12.1.5. InView Male External Catheters
      • 9.12.1.6. Extended Wear Male External Catheter
      • 9.12.1.7. Everyday Male External Catheter
  • 9.13. Medcomp
    • 9.13.1. Long Term Hemodialysis Catheters
      • 9.13.1.1. Split Cath
      • 9.13.1.2. Split Stream
      • 9.13.1.3. Eschelon
      • 9.13.1.4. Bio-Flex Tesio Cath
      • 9.13.1.5. Titan HD
      • 9.13.1.6. Hemo Flow
      • 9.13.1.7. Hemo-Cath LT
  • 9.14. Prolinx GmbH
    • 9.14.1. ProCath® Silicone-Elastomer Coated Foley Catheters
    • 9.14.2. ProCath® Silicone Foley Catheter
    • 9.14.3. ProCath® Solo Intermittent Catheter
    • 9.14.4. ProCath® Plus Intermittent Catheter
    • 9.14.5. ProCath® Kit Plus Intermittent Catheter
    • 9.14.6. ProCath® Closed Urine Drainage Systems PL 2000
    • 9.14.7. ProCath® Bed Drainage Bag PL 2000E
    • 9.14.8. ProCath® Leg bag PL 500
    • 9.14.9. ProCath® Closed Urine Drainage Systems PL 1000
    • 9.14.10. Catheterization Kit
  • 9.15. Rochester Medical Corporation
    • 9.15.1. Male External Catheters
    • 9.15.2. Intermittent Catheters
    • 9.15.3. Silicone Foley Catheters
    • 9.15.4. Anti-Infection Foley Catheters
    • 9.15.5. Urethral Inserts

APPENDIX

  • Appendix 1: Guidelines for Indwelling Catheterization in Adults
  • Appendix 1.1: Transurethral or Suprapubic Catheterisation
  • Appendix 1.2: Short-Term and Long-Term Catheterization
  • Appendix 1.3: Closed Drainage System
  • Appendix 1.4: Alternatives to Placing an Indwelling Catheter
  • Appendix 1.5: Indications for Urethral Catheterization
  • Appendix 1.6: Contraindications for Urethral Catheterization
  • Appendix 1.7: Short-Term vs. Long-Term Catheterization
  • Appendix 1.8: Indications for Suprapubic Catheterization
  • Appendix 1.9: Contraindications for Suprapubic Catheterization
  • Appendix 1.10: Advantages of Suprapubic Catheterization
  • Appendix 1.11: Limitations of Suprapubic Catheters
  • Appendix 1.12: Equipment and Products for Catheterization
  • Appendix 1.12.1: Types of Catheters
  • Appendix 1.12.2: Catheter Material
  • Appendix 1.12.3: Catheter Diameter
  • Appendix 1.12.4: Catheter Length
  • Appendix 1.12.5: Catheter Tip Dewsign
  • Appendix 1.12.6: Drainage Bags
  • Appendix 2: Minimally Invasive Medical Technologies
  • Appendix 2.1: Market Share for Minimally-Invasive Medical Technologies
  • Appendix 2.2: Market Size and Growth
  • Appendix 2.3: Patient Demand for Minimally-Invasive Procedures
  • Appendix 2.4: Advances in Electrosurgical Tools
  • Appendix 2.5: Advances in Robotics
  • Appendix 2.6: Clinical Opportunities for Minimally-Invasive Medical Technologies
  • Appendix 3: High-Impact Emerging Medical Technologies
  • Appendix 3.1: Emerging Cardiology/Vascular Market
  • Appendix 3.1.1: Diagnostic Technologies
  • Appendix 3.1.1.1: Implantable Cardiac Pressure Monitors
  • Appendix 3.1.1.2: Ultra-Wideband Radar
  • Appendix 3.1.1.3: Bioimpedance Plethsmograph
  • Appendix 3.1.2: Therapeutic Technologies
  • Appendix 3.1.2.3: MRI-Compatible Pacemakers
  • Appendix 3.1.2.4: Ultrasound-Enhanced Thrombolytics
  • Appendix 3.1.2.5: Image-Guided Intracardiac Surgery (IGIS)
  • Appendix 3.1.2.6: Autologous Cell Therapy
  • Appendix 3.1.2.7: External Cardiac Basal Annuloplasty
  • Appendix 3.1.2.8: Symplicity Catheter/Therapeutic Renal Denervation Procedure
  • Appendix 3.1.2.9: Laser Circumferential Pulmonary Vein Ablation/Atrial Fibrillation Therapy
  • Appendix 3.1.2.10: Non-Invasive Cardiac Radiosurgery/CyberHeart
  • Appendix 3.2: Oncology Market
  • Appendix 3.2.1: Diagnostic Technologies
  • Appendix 3.2.1.1: Radioactive Trace Biomarker/FLT
  • Appendix 3.2.1.2: Vivo Confocal Microscopy / Skin Cancer Diagnosis
  • Appendix 3.2.1.3: Lung Cancer/Breath Test
  • Appendix 3.2.1.4: Magnetically-Charged Cancer Biomarker/MagArray Technology
  • Appendix 3.2.1.5: NIR Tissue Analyzer/Optical Tissue Analyzer
  • Appendix 3.2.2: Therapeutic Technologies
  • Appendix 3.2.2.1: Acoustic-Enhanced Chemotherapy
  • Appendix 3.2.2.2: Electrochemotherapy/Novo - TTF device
  • Appendix 3.2.2.3: MRI-Guided Laser Coagulation Therapy (LITT)/AutoLITT
  • Appendix 3.2.2.4: MRI-Guided Robotic Radiotherapy/Renaissance System
  • Appendix 3.2.2.5: PDT for Solid Tumors/Light Infusion Therapy
  • Appendix 3.2.2.6: Prostate Cooling Catheter/UroCool
  • Appendix 3.3: Gastrointestinal Market
  • Appendix 3.3.1: Diagnostic Technologies
  • Appendix 3.3.1.1: Urea Breath Test/Breath ID
  • Appendix 3.3.1.2: Robotic GI Capsule
  • Appendix 3.3.1.3: Minimally Invasive GERD Procedure/EndoFlip
  • Appendix 3.3.2: Therapeutic Technologies
  • Appendix 3.3.2.1: Non-Invasive Obesity Treatment/LINX Reflux Management
  • Appendix 3.4: Pulmonology Market
  • Appendix 3.4.1: Diagnostic Technologies
  • Appendix 3.4.1.1: Electrical Impedance Tomography/EIT Lung Function
  • Appendix 3.4.2: Therapeutic Technologies
  • Appendix 3.4.2.1: Artificial Lung/Hemolung
  • Appendix 3.4.2.2: Endobronchial Valves/Spiration's® IBV
  • Appendix 3.5: Nursing
  • Appendix 3.5.1: Diagnostic Technologies
  • Appendix 3.5.1.1: Real-Time Blood Test Glucose, Electrolytes, Amino Acids/MicroEye
  • Appendix 3.5.1.2: Drug Metabolism/Breath-Based P450
  • Appendix 3.5.2: Therapeutic Technologies
  • Appendix 3.5.2.1: Contrast-Induced Nephropathy/RenalGuard Therapy
  • Appendix 3.5.2.2: Antimicrobial Coating on Catheters/CeraShield
  • Appendix 3.5.2.3: Sepsis Microfilter
  • Appendix 3.6: Neurology
  • Appendix 3.6.1: Diagnostic Technologies
  • Appendix 3.6.1.1: Electric Impedance Myography
  • Appendix 3.6.1.2: Brain Injury Blood Test/S100B Biomarker
  • Appendix 3.6.1.3: Alzheimer's Blood Test/NuroPro, LymPro Test
  • Appendix 3.6.1.4: Navigated Brain Stimulation Mapping/eXimia NBS System
  • Appendix 3.6.2: Therapeutic Technologies
  • Appendix 3.6.2.1: Deep Brain Stimulation/Stroke Therapy
  • Appendix 3.6.2.2: Hypoglossal Nerve Stimulation/Sleep Apnea
  • Appendix 3.6.2.3: Alzheimer's Therapeutic Drug/PBT2
  • Appendix 3.6.2.4: Spinal Cord Nerve Regeneration/Andara™ OFS
  • Appendix 3.7: Women's Health
  • Appendix 3.7.1: Non-Invasive Fetal EKG
  • Appendix 3.7.2: Cervical Spectroscopy/Optical Cervical Cancer Detection
  • Appendix 3.7.3: Laser Opto-Acoustic Imaging/Mammography
  • Appendix 3.8: Surgical
  • Appendix 3.8.1: Intraoperative Near-Infrared Guidance Technology
  • Appendix 3.8.2: Acoustic Hemostasis
  • Appendix 3.8.3: Photochemical Bonding
  • Appendix 3.9: Imaging
  • Appendix 3.9.1: Elastography/Advanced Ultrasound
  • Appendix 3.9.2: Computer-Assisted Tortuosity/Tumor Blood Vessel Analysis
  • Appendix 3.9.3: Dynamic Light Scattering/Early Cataract Detection
  • Appendix 4: A Guide for U.S. Exporters of Healthcare Technologies
  • Appendix 4.1: Opportunities in the E.U.
  • Appendix 4.2: U.S. Opportunities in Austria
  • Appendix 4.3: Opportunities in Belgium
  • Appendix 4.4: Opportunities in Bulgaria
  • Appendix 4.5: Opportunities in Czech Republic
  • Appendix 4.6: Opportunities in Denmark
  • Appendix 4.7: Opportunities in Finland
  • Appendix 4.8: Opportunities in France
  • Appendix 4.9: Opportunities in Germany
  • Appendix 4.10: Opportunities in Greece
  • Appendix 4.11: Opportunities in Hungary
  • Appendix 4.12: Opportunities in Ireland
  • Appendix 4.13: Opportunities in Italy
  • Appendix 4.14: Opportunities in Netherlands
  • Appendix 4.15: Opportunities in Norway
  • Appendix 4.16: Opportunities in Poland
  • Appendix 4.17: Opportunities in Romania
  • Appendix 4.18: Opportunities in Slovak Republic
  • Appendix 4.19: Opportunities in Spain
  • Appendix 4.20: Opportunities in Sweden
  • Appendix 4.21: Opportunities in Switzerland
  • Appendix 4.22: Opportunities in Ukraine
  • Appendix 4.23: Opportunities in U.K.
  • Appendix 4.24: Opportunities in Argentina
  • Appendix 4.25: Opportunities in Brazil
  • Appendix 4.26: Opportunities in Dominican Republic
  • Appendix 4.27: Opportunities in Equador
  • Appendix 4.28: Opportunities in El Salvador
  • Appendix 4.29: Opportunities in Mexico
  • Appendix 4.30: Opportunities in Panama
  • Appendix 4.31: Opportunities in Israel
  • Appendix 4.32: Opportunities in Saudi Arabia
  • Appendix 4.33: Opportunities in Turkey
  • Appendix 4.35: Opportunities in China
  • Appendix 4.36: Opportunities in India
  • Appendix 4.37: Opportunities in Indonesia
  • Appendix 4.38: Opportunities in Japan
  • Appendix 4.39: Opportunities in Philippines
  • Appendix 4.40: Opportunities in Republic of Korea
  • Appendix 4.41: Opportunities in Singapore
  • Appendix 4.42: Opportunities in Taiwan
  • Appendix 5: A Snapshot of Medical Device Industry, Based on a Survey by Professionals
  • Appendix 5.1: Change in Domestic Sales in 2011
  • Appendix 5.2: Companies Seeking Outside Opportunities for Medical Devices
  • Appendix 5.3: Continued International Expansion of Medical Device Firms in 2011
  • Appendix 5.4: Emerging Markets Targeted by Medical Device Firms in 2012
  • Appendix 5.5: Markets Offering the Best Growth Potential for the Next Five Years
  • Appendix 5.6: The Biggest Challenges in Running a Medical Device Business
  • Appendix 5.7: Prospects for Existing Medical Device Firms in 2012
  • Appendix 5.8: Medical Device Firm's Outlook on Overall Business Environment in 2012
  • Appendix 6: Medtech Mergers and Acquisitions, 2011
  • Appendix 6.1: J & J's Acquisition of Synthes
  • Appendix 6.2: Stryker's Strike
  • Appendix 6.3: The Battle Won by Danaher
  • Appendix 6.4: Major Acquisition for Private Equity Firm
  • Appendix 6.5: Thermo Fisher's Hook on Diagnostics Companies
  • Appendix 6.6: Other Diagnostics Transactions
  • Appendix 6.7: Pelvic Health Transactions
  • Appendix 6.8: Diversification Move by Dentsply
  • Appendix 6.9: Gentinge's Foray into Cardiovascular Sector
  • Appendix 6.10: Medtronic's Hyperactive Year
  • Appendix 6.11: Acquisition of U.S. Companies by Japanese
  • Appendix 6.12: Boston Scientific's Acquisition Trail
  • Appendix 6.13: Future Outlook
  • Appendix 7: Hospital Acquired Infections in Europe
  • Appendix 7.1: Urinary Tract Infections
  • Appendix 7.2: Respiratory Infections
  • Appendix 7.3: Blood Stream Infections
  • Appendix 7.4: Surgical Site Infections
  • Appendix 7.5: Other Infections
  • Appendix 7.6: An Overview of Hospital-Acquired Infections (HAI)
  • Appendix 7.7: Prevalence of HAI in Europe
  • Appendix 7.8: Microorganisms Isolated from HAIs
  • Appendix 7.9: Hospitals and Infections
  • Appendix 7.9.1: HAIs Based on Wards
  • Appendix 7.9.2: HAIs from Intensive Care Units
  • Appendix 7.10: An Overview of Urinary Tract Infections
  • Appendix 7.10.1: Catheter Associated Urinary Tract Infections (CAUTI)
  • Appendix 7.10.2: HAIs UTI Population in Europe
  • Appendix 7.11: Hospital-Acquired Pneumonia Infections
  • Appendix 7.11.1: Hospital-Acquired Pneumonia Infection in ICUs
  • Appendix 7.12: Surgical Site Infections
  • Appendix 7.12.1: SSI in Orthopedic Surgery
  • Appendix 7.13: Bloodstream Infections
  • Appendix 7.13.1: Catheter-Related Bloodstream Infections
  • Appendix 7.14: Antimicrobial Resistence
  • Appendix 7.15: HAIs in France
  • Appendix 7.16: HAIs in Germany
  • Appendix 7.17: HAIs in Italy
  • Appendix 7.18: HAIs in Spain
  • Appendix 7.19: HAIs in U.K.
  • Appendix 8: IV Catheter Needlestick Prevention in Europe
  • Appendix 8.1: Occurrence of Needlestick Injuries
  • Appendix 8.2: Transmissable Diseases
  • Appendix 8.2.1: Hepatitis B Virus (HBV) Infection
  • Appendix 8.2.2: Hepatitis C Virus Infection (HCV)
  • Appendix 8.2.3: HIV/AIDS
  • Appendix 8.3: Safety Devices in Catheters

INDEX OF FIGURES

  • Figure 2.1: Insertion of Foley Catheters into Male and Female Urinary Tracts
  • Figure 3.1: Projection for All Cardiovascular Disease Prevalence (%) in the U.S., 2010-2030
  • Figure 3.2: Projected Direct Medical Cost of All Cardiovascular Diseases in the U.S., 2010-2030
  • Figure 3.3: Projections for the Prevalence of Hypertension in the U.S., 2010-2030
  • Figure 3.4: Projected Direct Medical Cost of Hypertension in the U.S., 2010-2030
  • Figure 3.5: Projections for the Prevalence of Coronary Heart Disease in the U.S., 2010-2030
  • Figure 3.6: Projected Direct Medical Cost of Coronary Heart Disease in the U.S., 2010-2030
  • Figure 3.7: Projections for the Prevalence of Heart Failure in the U.S., 2010-2030
  • Figure 3.8: Projected Direct Medical Cost of Heart Failure in the U.S., 2010-2030
  • Figure 3.9: Projections for the Prevalence of Stroke in the U.S., 2010-2030
  • Figure 3.10: Projected Direct Medical Cost of Stroke in the U.S., 2010-2030
  • Figure 3.11: Ischemic Heart Disease, Mortality Rates in Selected OECD Countries, 2009
  • Figure 3.12: Stroke Mortality Rates in Selected OECD Countries, 2009
  • Figure 3.13: Total Worldwide Cardiovascular Devices Market, 2011-2018
  • Figure 3.14: Leaders in Cardiovascular Devices Market
  • Figure 3.15: Estimated New Cancer Cases in the U.S. for Select Sites, 2011
  • Figure 3.16: All Cancers Mortality Rates in Selected OECD Countries, 2009
  • Figure 3.17: Lung Cancer Mortality Rates in Selected OECD Countries, 2009
  • Figure 3.18: Breast Cancer Mortality Rates in Selected OECD Countries, 2009
  • Figure 3.19: Prostate Cancer Mortality in Males in Selected OECD Countries, 2009
  • Figure 3.20: Global Oncology Market, 2011-2018
  • Figure 3.21: Prevalence of Patients Undergoing Dialysis in OECD Countries, 1990 and 2009
  • Figure 3.22: Prevalence of Patients Living with a Functioning Kidney Transplant, 1990 and 2009
  • Figure 3.23: Worldwide Dialysis Market, 2011-2018
  • Figure 3.24: Global Number of Dialysis Patients, 2011
  • Figure 3.25: Number of U.S. Dialysis Patients, 2011-2018
  • Figure 3.26: U.S. Dialysis Market, 2011-2018
  • Figure 3.27: U.S. Dialysis Procedures by Segment, 2011
  • Figure 4.1: Worldwide market for Medical Devices, 2011-2018
  • Figure 4.2: Medical Device Market in Americas, 2011-2018
  • Figure 4.3: Medical Device Market in Western Europe, 2011-2018
  • Figure 4.4: Medical Device Market in Central and Eastern Europe, 2011-2018
  • Figure 4.5: Medical Device Market in Asia/Pacific, 2011-2012
  • Figure 4.6: Medical Device Market in Middle East/Africa, 2011-2018
  • Figure 4.7: Combined Chinese and Indian Market for Medical Devices, 2011-2018
  • Figure 5.1: Global Catheter Market Sales Segmentation
  • Figure 5.2: Global Catheter Market, 2011-2018
  • Figure 5.3: Market for Catheters in Americas, 2011-2018
  • Figure 5.4: Catheter Market in Europe, Middle East, Russia and Africa, 2011-2018
  • Figure 5.5: Catheter Market in Asia/Pacific, 2011-2018
  • Figure 5.6: Catheter Market in Japan, 2011-2018
  • Figure 5.7: Global Catheter Market by Region, 2011
  • Figure 5.8: Global Catheter Market by Segmentation in 2014
  • Figure 5.9: Global Market for Cardiovascular Catheters, 2011-2018
  • Figure 5.10: Global Diagnostic Cardiac Catheter Market by Type, 2011
  • Figure 5.11: Global Market for Balloon Catheters, 2011-2018
  • Figure 5.12: Estimated Addressable U.S. Market for Drug-Coated Balloon Catheters
  • Figure 5.13: U.S. Market for Drug Coated Balloon Catheters in Peripheral Applications
  • Figure 5.14: Global Market for Electrophysiology Ablation Catheters, 2011-2018
  • Figure 5.15: North American Market for Electrophysiology Ablation Catheters, 2011-2018
  • Figure 5.16: European Market for Electrophysiology Ablation Catheters, 2011-2018
  • Figure 5.17: Asia/Pacific Market for Electrophysiology Ablation Catheters, 2011-2018
  • Figure 5.18: Global Single Use Device (SUD) Cardiac Catheter Market, 2011-2018
  • Figure 5.19: Global Market for SUD Cardiac Catheters Used in Conventional Diagnostics, 2011-2018
  • Figure 5.20: Global Market for SUD Cardiac Catheters Used in Standard Ablation, 2011-2018
  • Figure 5.21: Global Market for SUD Cardiac Catheters Used in Advanced Diagnostics, 2011-2018
  • Figure 5.22: Global Market for SUD Cardiac Catheters Used in Irrigated Ablation, 2011-2018
  • Figure 5.23: Global Market for Urological Catheters, 2011-2018
  • Figure 5.24: Manufacturers with Largest Number of FDA-Approved Catheters
  • Figure 5.25: U.S. Urology Device Market by Segment, 2011
  • Figure 5.26: U.S. Intermittent Catheter Market, 2011-2018
  • Figure 5.27: Market Leaders in Intermittent Catheters
  • Figure 5.28: Market Leaders in Foley Catheters
  • Figure 5.29: U.S. Market Share of Urinary Incontinence Products by Type
  • Figure 5.30: U.S. Urinary Incontinence Market by Sub-Segment, 2011
  • Figure 5.31: Market Leaders in Male External Catheters
  • Figure 5.32: Global Market for Central Venous Catheters, 2011-2018
  • Figure 5.53: CVC Global Market by Region/Country
  • Figure 5.54: Leaders in the Global Central Venous Catheter Market
  • Figure 5.55: U.S. Market Leaders in Implantable Catheter Ports, 2010
  • Figure 6.1: Relative Share of Ablation Technologies Market by Clinical Specialty, 2010
  • Figure 6.2: Global Ablation Devices Market by Device Type, 2011
  • Figure 6.3: Global Market for Electrical Ablation Devices, 2011-2018
  • Figure 6.4: Global Market for Radiation Ablation Devices, 2011-2018
  • Figure 6.5: Global Market for Light-Based Ablation Devices, 2011-2018
  • Figure 6.6: Global Market for Radiofrequency Ablation Devices, 2011-2018
  • Figure 6.7: Market Leaders in RF Ablation Devices, 2011
  • Figure 6.8: Global Market for Ultrasound Ablation Devices, 2011-2018
  • Figure 6.9: Global Market for Cryotherapy Ablation Devices, 2011-2018
  • Figure 6.10: Global Market for Thermal Ablation Devices, 2011-2018
  • Figure 6.11: Global Market for Microwave Ablation Devices, 2011-2018
  • Figure 6.12: Global Market for Hydromechanical Ablation Devices, 2011-2018
  • Figure 6.13: U.S. Market for Tissue Ablation Devices, 2011-2018
  • Figure 6.14: U.S. Market for Cryoablation Devices, 2011-2018
  • Figure 6.15: U.S. Market for Hydromechanical Ablation Devices, 2011-2018
  • Figure 6.16: U.S. Market for Ultrasound Ablation Devices, 2011-2018
  • Figure 6.17: U.S. Market for Radiofrequency Ablation Devices, 2011-2018
  • Figure 6.18: Asia/Pacific Market for Ablation Devices, 2011-2018
  • Figure 6.19: Growth in Japanese Market for Ablation Technologies, 2011-2018
  • Figure 6.20: Growth in Chinese Market for Ablation Technologies, 2011-2018
  • Figure 6.21: Growth in Australian Market for Ablation Technologies, 2011-2018
  • Figure 6.22: Growth in Indian Market for Ablation Technologies, 2011-2018
  • Figure 6.23: Relative Share of Ablation Technologies Market by Clinical Specialty, 2010
  • Figure 6.24: Cancer Ablation Market Segmentation, 2011
  • Figure 6.25: Global Ablation Technologies Market by Modality, 2011
  • Table 9.1 IV Catheters from BD
  • Figure A.2.1: Number of Minimally-Invasive Surgeries Worldwide
  • Figure A2.2: Market for Minimally-Invasive Medical Technologies by Region/Country, 2009-2014
  • Figure A2.3: Market Share of Minimally-Invasive Medical Technologies by Device Type
  • Figure A2.4: Profound Medical's Energy Wand Emitting Ultrasound in Two Different Wavelengths
  • Figure A2.5: Coil RFA Ablation Technology for Treating Solid Tumors
  • Figure A4.1: French Medical Device Market Size, 2009-2011
  • Figure A4.2: German Medical Market, 2009-2011
  • Figure A4.3: Size of Turkey's Medical Device Market, 2010-2012
  • Figure A4.4: Medical Device Market in Republic of Korea, 2008-2010
  • Figure A5.1: Change in Domestic Sales by Medical Device Companies in 2011
  • Figure A5.2: Change in International Sales of Medical Devices in 2011
  • Figure A5.3: Continued International Expansion of Medical Device Firms in 2011
  • Figure A5.4: Emerging Markets Targeted by Medical Device Firms in 2012
  • Figure A5.5: Markets Offering the Best Growth Potential from 2012-2017
  • Figure A5.6: Biggest Challenges in Running a Medical Device Business
  • Figure A5.7: Prospects for Existing Medical Device Firms in 2012
  • Figure A5.8: Medical Device Firm's Outlook on Overall Business Environment in 2012
  • Figure A7.1: Hospital-Acquired Infections: Percent Split by Type in Europe
  • Figure A7.2: HAIs of Urinary Tract Infections (UTI) Percent by Type
  • Figure A7.3: HAIs of Urinary Tract Percent Split by Pathogens
  • Figure A7.4: Population of HIS UTI Population in Europe by Country
  • Figure A7.5: Six Most Common Pathogens of Pneumonia Infection in ICUs
  • Figure A7.6: Incidence of SSI by Type of Orthopedic Surgery
  • Figure A7.7: Bloodstream Infections by Site of Origin
  • Figure A7.8: HAIs in France by Type
  • Figure A7.9: HAIs in Germany by Type
  • Figure A7.10: HAIs in Spain by Type of Pathogen
  • Figure A7.11: HAIs in the U.K. by Type
  • Figure A8.1: Frequency of Needlestick Injuries in Europe and the U.S.
  • Figure A8.2: Occurrence of Needlestick Injuries
  • Figure A8.3: The Three Dangerous Infections through Needlestick Injuries
  • Figure A8.4: Percent Population of Chronic HBV Infected People by Region
  • Figure A8.5: The Prevalence Rate of Chronic Hepatitis C Virus in Europe
  • Figure A8.6: The Prevalence Rate of Chronic Hepatitis C Virus in Europe
  • Figure A8.7: People Living with HIV by Region

INDEX OF TABLES

  • Table 7.1: Medicare Fee Schedule for Common Cath Procedure Codes in the State of Washington
  • Table 7.2: Payer Mix for Cath Procedures
  • Table 7.3: Projected Revenue in Free Standing Cath Lab
  • Table 7.4: Suggested Minimal Room Sizes in a Cardiac Cath Suite
  • Table 7.5: Medicare Reimbursement 2009: Hospital O.P Department vs. Free Standing Cath Lab
  • Table 7.6: Revenue Projections Based on 50% Practice
  • Table 8.1: Codes and Payments for Catheter Procedures, 2012
  • Table A4.1: The Top Three Countries in the Export and Import of Medical Devices into China, 2010
  • Table A6.1: Medtech Merger and Acquisition, 2011
  • Table A7.1: Pathogens Causing CAUTI Ranked in Order
  • Table A7.2: Classification of Pathogens Based on the Onset of Pneumonia
  • Table A7.3: MRSA Incidence per 100,000 Patient Days in Europe
  • Table A7.4: List of Antibiotic Resistent Pathogens
  • Table A7.5: Economic Burden of Infections Due to Antibiotic-Resistant Bacteria
Show More
Pricing